Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Carol D. Cheli
Introduction
Carol D. Cheli is a notable inventor based in Mahopac, NY (US). She has made significant contributions to the field of medical diagnostics, particularly in relation to prostate cancer. Her work focuses on innovative methods that enhance the understanding and treatment of this prevalent disease.
Latest Patents
Carol D. Cheli holds a patent titled "Serum levels of HER2/neu as an indicator of clinical state and prognosis of prostate cancer." This invention relates to methods of diagnosing prostate cancer, predicting disease progression, prognosing the stage and state of the disease, and identifying appropriate treatment indications for patients. The methods encompass determining the levels of HER-2/neu in fluid biological samples, such as blood and serum, from patients.
Career Highlights
Cheli is associated with Siemens Healthcare Diagnostics GmbH, where she applies her expertise in medical diagnostics. Her work has been instrumental in advancing the understanding of prostate cancer and improving patient outcomes through innovative diagnostic methods.
Collaborations
One of her notable collaborators is Samir S. Taneja, with whom she has worked closely on various projects related to prostate cancer diagnostics.
Conclusion
Carol D. Cheli's contributions to the field of medical diagnostics, particularly in prostate cancer, highlight her innovative spirit and dedication to improving patient care. Her patent and ongoing work continue to influence the landscape of cancer diagnostics.